Trade IRLA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
IRulya Therapeutics Inc. (IRLA) is trading at US$32.83, down 5.33% today as of Oct 22, 16:00 EDT. The company has a market capitalisation of US$28.34M. Over the past 52 weeks, IRLA has traded between US$15.10 and US$909.98. On Syfe you can trade IRLA with $0 commission and add it to your watchlist.
| Previous close | US$34.68 |
|---|---|
| Market cap | US$28.34M |
| 52-week range | US$15.10 – US$909.98 |
| Volume | 165.57K |
| Exchange | US |
IRulya Therapeutics Inc.
IRulya Therapeutics, Inc. is a biopharmaceutical company, which engages in unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes eDSP, developed using their proprietary Autologous Intracellular Drug Encapsulation (AIDE) technology platform, which is a novel device combination that uses an automated process designed to encapsulate a drug into the patient’s own red blood cells. The company was founded by Casey Crawford Lynch, Stephen Dominy and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.
IRulya Therapeutics Inc. (IRLA) stock is trading at US$32.83, -5.33% from the previous close of US$34.68.
The market cap for IRulya Therapeutics Inc. (IRLA) stock is approximately US$28.34M.
The 52-week high for IRulya Therapeutics Inc. (IRLA) stock is US$909.98.
The 52-week low for IRulya Therapeutics Inc. (IRLA) stock is US$15.10.
IRulya Therapeutics Inc. (IRLA) does not currently pay a dividend.
Stay on top of IRLA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
